Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma Weisong XuEdwin de ZoetenE. P. Cohen ORIGINAL ARTICLE Pages: 217 - 224
Early-appearing tumor-infiltrating natural killer cells play an important role in the nitric oxide production of tumor-associated macrophages through their interferon production Koichiro AbeMamoru HaradaKikuo Nomoto ORIGINAL ARTICLE Pages: 225 - 233
Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients C. A. SavaryMonica L. GrazziuttiJohn H. Rex ORIGINAL ARTICLE Pages: 234 - 240
The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back A. M. BerghellaPatrizia PellegriniCarlo Umberto Casciani ORIGINAL ARTICLE Pages: 241 - 249
Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon γ and lipopolysaccharide Burkhard HennemannGabriele BeckmannR. Andreesen ORIGINAL ARTICLE Pages: 250 - 256
Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model G. RaesJ. Van GinderachterAnja Geldhof ORIGINAL ARTICLE Pages: 257 - 265
Construction and characterization of a fusion protein of single-chain anti-carcinoma antibody 323/A3 and human β-glucuronidase H. J. HaismaRudd H. BrakenhoffEpie Boven ORIGINAL ARTICLE Pages: 266 - 272
Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor Akiko IwasakiB. H. Barber ORIGINAL ARTICLE Pages: 273 - 279
